Elaiophylin triggers paraptosis and preferentially kills ovarian cancer drug-resistant cells by inducing MAPK hyperactivation
Guannan Li(Tongji Hospital), Qinglei Gao(Tongji Hospital), Hui‐Ling Lai(Sun Yat-sen University), Jianfeng Zhou(Tongji Hospital), Ding Ma(Fudan University Shanghai Cancer Center), Xiaoyuan Huang(Tongji Hospital), Ru-Qi Chen(Tongji Hospital), Shen-Nan Shi(Zhejiang Chinese Medical University), Jiahong Tan(Tongji Hospital), Danmei Yan(Tongji Hospital), Jiahao Liu(Nantong University), Zeyu Zhang(Zhejiang Chinese Medical University), Yang Yang(Tongji Hospital), Zhen Wang(Nanjing Agricultural University), Huayi Li(Tongji Hospital), Xuejiao Zhao(Cancer Research Center), Yong Fang(Tongji Hospital), Meng-Shi Luo(Tongji Hospital)
Cited by 104
Related Papers
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial
|Journal of Thoracic Oncology|2021|311
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
|Journal of Hematology & Oncology|2017|256
Music improves sleep quality in older adults
|Journal of Advanced Nursing|2005|248